Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Clin Radiol ; 77(8): e652-e659, 2022 08.
Article in English | MEDLINE | ID: mdl-35710528

ABSTRACT

AIM: To clarify the usefulness and accuracy of segmental adrenal venous sampling (sAVS) on localisation and functional diagnosis of various adrenal lesions in primary aldosteronism. MATERIALS AND METHODS: Consecutive patients (n=162) who underwent adrenalectomy and 138 patients indicated for medication following sAVS were analysed retrospectively. Based on immunohistopathological diagnosis, the positive predictive value (PPV) of computed tomography (CT)-detectable aldosterone-producing adenoma (APA) was calculated. Moreover, endocrinological and sAVS characteristics were analysed quantitatively and qualitatively among APA, CT-undetectable aldosterone-producing nodules (APNs), multiple aldosterone-producing micronodules (MAPM), and medication groups. RESULTS: The PPV of APA by sAVS was 137/141 (97.1%; 95% confidence interval, 92.9-99.2%). Compared to the medication cases, the APA group showed stronger disease activity clinically and significant differences in adrenal hormones, such as a higher aldosterone level and aldosterone-to-cortisol ratio, and lower cortisol levels in the adrenal central vein and aldosterone maximum tributaries on the dominant side after cosyntropin stimulation. The APA group shows focal aldosterone hypersecretion, such as mean number of aldosterone elevated segments (1.7 ± 0.7 versus 2 ± 0.9, p=0.003) and presence of aldosterone-not-elevated segments (93% versus 41%, p<0.001). Clinically and in terms of sAVS, APN and MAPM showed similar characteristics to APA and to the medication cases, respectively. CONCLUSION: sAVS can localise functionally active tissues of CT-detectable and CT-undetectable lesions enabling decisions on surgical or medical treatment.


Subject(s)
Aldosterone , Hyperaldosteronism , Adrenal Glands/blood supply , Adrenal Glands/diagnostic imaging , Humans , Hydrocortisone , Hyperaldosteronism/diagnostic imaging , Hyperaldosteronism/pathology , Retrospective Studies
2.
Tissue Cell ; 37(1): 25-35, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15695173

ABSTRACT

We examined the roles of the PI3K-AKT signalling pathway in fetal lung development. By Western blotting, phosphorylated AKT (pAKT) was highly expressed in fetal days 12 and 14 with decreased expression thereafter. By immunohistochemistry, pAKT was expressed mainly in the respiratory epithelium of early fetal days. We examined the effects of fibroblast growth factor 1 (FGF1), PI3K inhibitors (LY294002 and wortmannin), MAPK inhibitor (PD98059) and both of FGF1 and each inhibitor on lung morphogenesis, BrdU incorporation and apoptosis. In the FGF1-treated explants, the number of terminal buds and BrdU-labelled cells increased significantly, while the LY294002-, wortmannin-, PD98059-treated explants demonstrated obvious decreases. The effects by FGF1 were inhibited by LY294002, wortmannin and PD98059. Regardless of the presence of FGF1, the LY294002-, wortmannin- and PD98059-treated explants increased apoptosis revealed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling assay in the mesenchyme of the explants. At the same time, the effect of LY294002, wortmannin, PD98059 on expression of surfactant apoprotein C (SPC) were also studied. The LY294002 and wortmannin treatments showed decreased expression of SPC. These findings suggest that the PI3K-AKT signalling pathway plays a pivotal role in mouse lung development through various biological processes.


Subject(s)
Fetal Development/physiology , Lung/embryology , Phosphatidylinositol 3-Kinases/physiology , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins/physiology , Signal Transduction , Androstadienes/pharmacology , Animals , Apoptosis/drug effects , Cell Survival , Chromones/pharmacology , Extracellular Signal-Regulated MAP Kinases/biosynthesis , Fibroblast Growth Factor 1/pharmacology , Flavonoids/pharmacology , Gene Expression Regulation, Developmental , In Situ Nick-End Labeling , MAP Kinase Signaling System , Mice , Mice, Inbred ICR , Morpholines/pharmacology , Organ Culture Techniques , Phosphoinositide-3 Kinase Inhibitors , Protein Serine-Threonine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins c-akt , Wortmannin
3.
Gene Ther ; 9(12): 828-31, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12040466

ABSTRACT

Apoptosis-inducing caspases have been tested for immunomodulatory effect on a gene gun-delivered DNA vaccine which expresses influenza hemagglutinin. Attenuated murine caspase 2 and a chimera of murine caspase 2 prodomain and human caspase 3 strongly enhanced humoral and cell-mediated immune response to hemagglutinin when they were co-administered with an immunogen DNA. In contrast, wild-type caspases did not enhance the DNA-raised immune response. Caspase dose-dependent antibody response curve revealed that the antibody level was in inverse relation to the amount of administered caspase. These findings indicate that bland apoptosis of antigen-harboring cells can elicit enhanced immune responses. Extensive apoptosis interferes with the generation of immune response. Gene gun delivery involving caspases elicited type-2 immune responses that characterized with dominant IL-4 and IgG1 production. ELISPOT assays showed that CD4 T cells were preferentially activated, while CD8 T cell response remained at marginal level. Using attenuated caspases for gene gun DNA vaccination is a useful approach to amplify type-2 immune responses.


Subject(s)
Apoptosis , Biolistics , Caspases/genetics , Influenza Vaccines/administration & dosage , Vaccines, DNA/administration & dosage , Adjuvants, Immunologic , Animals , CD4-Positive T-Lymphocytes/immunology , Hemagglutinins/genetics , Immunoglobulin G/immunology , Influenza Vaccines/immunology , Interleukin-4/immunology , Lymphocyte Activation , Mice
4.
Cell Prolif ; 34(4): 233-41, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11529881

ABSTRACT

We examine the cell proliferation activity and expression of cyclin-dependent kinase inhibitors of the Cip/Kip family, p21Cip1, p27Kip1 and p57Kip2, in foetal hamster lungs to determine the expression patterns of the cyclin-dependent kinase inhibitors and to clarify the relationship between expression of the cyclin-dependent kinase inhibitors and lung development. Foetal hamster lungs on gestational days 12.5-16 (the day of birth) and adult lungs were fixed in 4% paraformaldehyde. Frozen sections were immunostained for the cyclin-dependent kinase inhibitors, and examined by immunostaining for Ki-67 and bromodeoxyuridine to determine the proliferation activity of the foetal lungs. During the foetal period, cell proliferation activity, as analysed by Ki-67 or bromodeoxyuridine labelling, decreased with development of the lung. In contrast to the gradual decrease of cell proliferation activity, cells with p27Kip1 immunoreactivity increased with development. On the other hand, p21Cip1-positive cells were most prominent around gestational day 14.5, while after birth positive cells decreased markedly. A few p57Kip2-positive cells were detected in the bronchiolar epithelium on gestational day 14.5. Western blotting analyses confirmed these immunostaining patterns. Thus, the levels of the cyclin-dependent kinase inhibitors of the Cip/Kip family are modulated in the lungs during the foetal period, and each shows a unique expression pattern. The cyclin-dependent kinase inhibitors may play roles not only in regulating cell proliferation activity but also in regulating other functions such as differentiation in the lung during the foetal period.


Subject(s)
Cell Cycle Proteins/metabolism , Cyclins/metabolism , Lung/embryology , Lung/metabolism , Nuclear Proteins/metabolism , Tumor Suppressor Proteins , Aging/metabolism , Animals , Blotting, Western , Bromodeoxyuridine , Cell Division , Cricetinae , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclin-Dependent Kinase Inhibitor p57 , Cyclin-Dependent Kinases/antagonists & inhibitors , Enzyme Inhibitors/metabolism , Immunohistochemistry , Ki-67 Antigen/metabolism , Lung/cytology , Male , Mesocricetus
5.
Pathol Res Pract ; 197(3): 205-10, 2001.
Article in English | MEDLINE | ID: mdl-11314786

ABSTRACT

A case of thymic carcinosarcoma in an 83-year-old Japanese man is presented. He died of superior vena cava syndrome caused by a rapidly enlarged anterior mediastinum tumor eight months after initial symptoms. Autopsy revealed a 16 x 12 x 25 cm-sized, tan yellow, whitish tumor with a multinodular and microcystic appearance located in the left anterior mediastinum, which involved the residual thymus. The tumor had directly invaded the left pleura, and had metastasized to the right lung and spleen. Histologic examinations of the primary tumor showed a sarcomatous component consisting of racquet- or spindle-shaped cells with cross striations, and small nests of atypical squamous cells scattered throughout the tumor; neither transition between the two components nor intermediate cells with both epithelial and mesenchymal features was seen. Electron microscopic and immunohistochemical examinations confirmed the rhabdomyomatous differentiation of the sarcomatoid component. To our knowledge, there have been only two reported cases showing histologic features similar to the present tumor. For the histogenesis of thymic carcinosarcoma, we propose two hypotheses. The first is that sarcomatous cells are derived from carcinomatous cells by tumoral metaplasia. Secondly, that this type of tumor originates from thymic primitive cells with multidirectional differentiation potential. In accordance with the latter, we consider that the present tumor originated from thymic primitive cells. Thymic carcinosarcoma is a highly malignant tumor, and most patients die within a year. Appropriate therapies must be developed.


Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinosarcoma/pathology , Neoplasms, Multiple Primary/pathology , Rhabdomyosarcoma, Embryonal/pathology , Thymus Neoplasms/pathology , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy, Needle , Carcinoma, Squamous Cell/chemistry , Carcinosarcoma/chemistry , Fatal Outcome , Humans , Immunohistochemistry , Lung Neoplasms/secondary , Male , Mitotic Index , Neoplasm Invasiveness , Phosphopyruvate Hydratase/analysis , Radiography, Thoracic , Rhabdomyosarcoma, Embryonal/chemistry , Splenic Neoplasms/secondary , Thymus Neoplasms/chemistry , Tomography, X-Ray Computed
6.
Tissue Cell ; 33(1): 25-32, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11292167

ABSTRACT

Taste buds are specialized epithelial cell clusters in the oral squamous cell epithelium. Although taste buds have been reported to renew rapidly, the mechanism of cell cycle control in these specialized structures remains unresolved. To clarify the cell cycle status and role of cyclin-dependent kinase inhibitors (CDKI) for cell cycle control in the taste buds, we analyzed cell proliferation activity using bromodeoxyuridine (BrdU) and Ki-67 immunostainings and the expression of the Cip/Kip family of CDKI (p21Cip1, p27Kip1, and p57Kip2) in the circumvallate papillae of mouse and hamster. BrdU-positive cells were detected in the basal layer of the oral epithelium. In the taste buds, Ki-67-positive cells were seen in the basal area, with only a very few positive cells in the taste buds. Both p21Cip1 and p27Kip1 positive cells were seen in the suprabasal layer of the non-gustatory oral epithelium. In the taste buds, stronger p27Kip1 staining was detected than in the non-gustatory epithelium. Western blotting analysis revealed that p27Kip1 was abundant in the mucosal tissues from circumvallate papillae. Thus, our study suggests that the taste bud cells except for basal cells are post-mitotic cells and that the cell cycle arrest associated with taste bud cell differentiation could be regulated predominantly by p27Kip1.


Subject(s)
Cell Cycle , Cyclin-Dependent Kinases/antagonists & inhibitors , Ki-67 Antigen/immunology , Mouth Mucosa/metabolism , Taste Buds/metabolism , Tumor Suppressor Proteins , Animals , Blotting, Western , Bromodeoxyuridine/metabolism , Cell Cycle Proteins/metabolism , Cell Division , Cricetinae , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclin-Dependent Kinase Inhibitor p57 , Cyclins/metabolism , Epithelial Cells/metabolism , Gene Expression , Immunohistochemistry , Male , Mesocricetus , Mice , Mice, Inbred C57BL , Nuclear Proteins/metabolism , Tongue/cytology
7.
Pathol Res Pract ; 196(9): 647-51; discussion 652, 2000.
Article in English | MEDLINE | ID: mdl-10997740

ABSTRACT

Chromophobe renal cell carcinoma (RCC) is a newly established entity of renal neoplasm with histological and molecular biological features different from those of common RCCs. Chromophobe RCC shows characteristically cloudy and reticular cytoplasm and cellular features resembling distal nephron. Its prognosis has been reported to be more favorable than that of common RCCs. Recently, however, several cases have been reported which showed sarcomatoid change to present poor prognosis. Here we present a case of chromophobe RCC with sarcomatoid change which was once resected surgically. The surgically resected tumor was histologically composed of chromophobe epithelial cell sheets and sarcomatoid elements. The former showed positivity for colloid iron staining, and was immunohistochemically positive for E-cadherin and epithelial membrane antigen (EMA), whereas the latter was positive for vimentin instead of colloid iron and E-cadherin. EMA was focally positive in the sarcomatoid element. The patient died with systemic metastases 14 months after the operation. Histologically, the metastatic tumors were composed only of sarcomatoid element lacking epithelial element. Based on these findings and previous reports, this case supports the existence of a tumor progression pathway from chromophobe to sarcomatoid RCC. It is necessary to perform careful postoperative investigation of chromophobe RCC due to its possible histological progression to the sarcomatoid subtype.


Subject(s)
Adenocarcinoma/pathology , Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Sarcoma/pathology , Adenocarcinoma/chemistry , Adenocarcinoma/therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cadherins/analysis , Carcinoma, Renal Cell/chemistry , Carcinoma, Renal Cell/therapy , Colloids , Coloring Agents , Cyclophosphamide/administration & dosage , Dacarbazine/administration & dosage , Doxorubicin/administration & dosage , Fatal Outcome , Female , Humans , Hydroxides , Immunohistochemistry , Kidney Neoplasms/chemistry , Kidney Neoplasms/therapy , Mucin-1/analysis , Neoplasms, Multiple Primary/chemistry , Neoplasms, Multiple Primary/therapy , Nephrectomy , Organic Chemicals , Sarcoma/chemistry , Sarcoma/therapy , Staining and Labeling , Vincristine/administration & dosage
8.
Development ; 127(18): 3913-21, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10952889

ABSTRACT

To clarify the mechanisms that regulate neuroendocrine differentiation of fetal lung epithelia, we have studied the expression of the mammalian homologs of achaete-scute complex (Mash1) (Ascl1 - Mouse Genome Informatics); hairy and enhancer of split1 (Hes1); and the expression of Notch/Notch-ligand system in the fetal and adult mouse lungs, and in the lungs of Mash1- or Hes1-deficient mice. Immunohistochemical studies revealed that Mash1-positive cells seemed to belong to pulmonary neuroendocrine cells (PNEC) and their precursors. In mice deficient for Mash1, no PNEC were detected. Hes1-positive cells belong to non-neuroendocrine cells. In the mice deficient in Hes1, in which Mash1 mRNA was upregulated, PNEC appeared precociously, and the number of PNEC was markedly increased. NeuroD (Neurod1 - Mouse Genome Informatics) expression in the lung was detected in the adult, and was enhanced in the fetal lungs of Hes1-null mice. Expression of Notch1, Notch2, Notch3 and Notch4 mRNAs in the mouse lung increased with age, and Notch1 mRNA was expressed in a Hes1-dependent manner. Notch1, Notch2 and Notch3 were immunohistochemically detected in non-neuroendocrine cells. Moreover, analyses of the lungs from the gene-targeted mice suggested that expression of Delta-like 1 (Dll1 - Mouse Genome Informatics) mRNA depends on Mash1. Thus, the neuroendocrine differentiation depends on basic helix-loop-helix factors, and Notch/Notch-ligand pathways may be involved in determining the cell differentiation fate in fetal airway epithelium.


Subject(s)
Cell Differentiation , Drosophila Proteins , Epithelial Cells/cytology , Helix-Loop-Helix Motifs , Lung/cytology , Lung/embryology , Transcription Factors/metabolism , Aging/genetics , Aging/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors , Body Constitution , Cell Count , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Epithelial Cells/metabolism , Gene Deletion , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Immunohistochemistry , Ligands , Lung/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , Nerve Tissue Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Notch , Stem Cells/cytology , Stem Cells/metabolism , Transcription Factor HES-1 , Transcription Factors/deficiency , Transcription Factors/genetics
9.
Pathol Int ; 50(3): 238-43, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10792788

ABSTRACT

Myoepithelioma of the lacrimal gland is extremely rare and only four cases, one of which was malignant, have been reported in detail. The present report describes a case of lacrimal gland myoepithelioma in a Japanese male with histological features suggestive of potentially malignant transformation. The excised tumor consisted of two components, a central nodular component and a peripheral component surrounding the former. These components were separated by a fibrous tissue. Microscopically, both components were comprised almost entirely of spindle-shaped cells, but with some epithelioid cells containing glycogen granules. Extracellular spaces in the peripheral component were filled with eosinophilic materials with the occasional crystalloid structures, which were immunoreactive for collagen type I. Neoplastic cells were immunoreactive focally for vimentin and S-100, but negative for cytokeratins, epithelial membrane antigen, muscle actin, smooth muscle actin, desmin, myosin, and glial fibrillary acidic protein. The neoplastic cells in the central component showed nuclear pleomorphism and atypia with a higher frequency of mitotic figures, and higher labelings of proliferation markers than those in the peripheral component. Neither invasion, necrosis, nor hemorrhage was observed in the tumor. From these findings we proposed a diagnosis of potentially malignant myoepithelioma.


Subject(s)
Lacrimal Apparatus Diseases/pathology , Myoepithelioma/pathology , Orbital Neoplasms/pathology , Adult , Humans , Lacrimal Apparatus Diseases/physiopathology , Male , Myoepithelioma/physiopathology , Orbital Neoplasms/physiopathology
10.
Am J Pathol ; 155(4): 1341-51, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10514416

ABSTRACT

To elucidate the role of p53 and apoptosis in the pathogenesis of lung injury, we examined histological changes, expressions of p53 and p21waf1/cip1 (p21), apoptosis, DNA double strand breaks, cell kinetics, and DNA synthesis in C57/BL6 mice (p53+/+) and mice deficient for p53 (p53-/-) at 2 hours to 7 days after a single intravenous administration of bleomycin. We also compared these parameters between the lung cells and small intestinal epithelial cells to explore potential differences in their response to DNA damage. Bleomycin induced p21 expression in a p53-dependent manner in p53+/+ mice but neither p53 nor p21 expression in p53-/- mice. In the lung of both groups of mice, focal inflammation followed by fibrosis was observed, but there was no evidence of apoptosis. Cells with DNA breaks and those undergoing DNA synthesis were unequivocally increased, but the cycling cell fraction remained unchanged, suggesting that the DNA synthesis detected in the lung reflected unscheduled DNA synthesis for repair of damaged DNA. DNA breaks and unscheduled DNA synthesis were prolonged in p53-/- mice compared to p53+/+ mice. By contrast, in the small intestine, marked cell cycle arrest and extensive apoptosis were evoked in the cycling crypt cells of both groups of mice, but these changes were milder and DNA breaks remained detectable for a longer time in p53-/- mice than in p53+/+ mice. Among the resting enterocytes in the villi, apoptosis was observed almost equally in both groups, but repair of DNA breaks was significantly delayed in the p53-/- mice. These observations imply that apoptosis is mediated largely by the p53-dependent pathway in the crypts but exclusively by the p53-independent pathway in the villi, that this pathway is particularly important in DNA repair in the villi, and that despite this difference in the significance of apoptosis, p53 plays an important role in DNA repair in both the crypts and villi. Our results suggest that the lung cells and small intestinal cells respond to the bleomycin treatment in different ways in terms of the induction of apoptosis and that p53 carries out an essential role in the early response to and repair of DNA damage by a non-apoptotic mechanism which appears to be crucial in the noncycling lung cells and enterocytes. Importantly, the p53-p21 pathway and apoptosis are unlikely to be essential for bleomycin-induced tissue injury in the lung.


Subject(s)
Bleomycin/toxicity , DNA Damage , Intestine, Small/drug effects , Lung/drug effects , Tumor Suppressor Protein p53/physiology , Animals , Apoptosis , Blotting, Western , Cell Death , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/biosynthesis , DNA/biosynthesis , Immunohistochemistry , In Situ Nick-End Labeling , Intestine, Small/pathology , Ki-67 Antigen/metabolism , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Specific Pathogen-Free Organisms , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics
11.
Histol Histopathol ; 14(2): 479-85, 1999 04.
Article in English | MEDLINE | ID: mdl-10212809

ABSTRACT

Small cell carcinoma is a rare neoplasm in the esophagus. To evaluate cell proliferation activity and its underlying mechanisms in this tumor, we examined immunohistochemically 5 cases of small cell carcinoma of the esophagus (SCCE) for expressions of tumor suppressor proteins, oncoproteins and cell proliferation markers including p53, p21WAF1/CIP1, retinoblastoma (Rb) protein, bcl-2, Ki-67 and PCNA, and compared the results with those of 5 cases of small cell carcinoma of the lung (SCCL) and 10 cases of squamous cell carcinoma of the esophagus (SQCE). The prevalence and labeling index of p53-immunoreactivity tended to be higher in SCCE (4/5; 56.6%) and SCCL (4/5; 79.9%) than in SQCE (6/10; 48.8%). Expression of p21WAF1/CIP1 was observed in 2 of 10 cases of SQCE. In contrast, its expression could not be detected in any cases of SCCE and SCCL examined. Expression of Rb protein was observed in 9 out of 10 cases of SQCE, but not in any cases of SCCE and SCCL. SCCE and SCCL showed more frequent and intense immunoreactivity for bcl-2 than SQCE. In expression of cell proliferation markers (Ki-67 and PCNA), no remarkable difference was observed among SCCE, SCCL and SQCE. These results suggest that SCCE and SCCL could share some genetic alternations including mutation of p53, loss of Rb gene and overexpression of bcl-2, and these may be related to the similar biological potentials between the two. Furthermore, SCCE was different from SQCE in expression of Rb protein and bcl-2, and these two types of esophageal carcinoma could arise through different molecular mechanisms.


Subject(s)
Carcinoma, Small Cell/metabolism , Carcinoma, Squamous Cell/metabolism , Cyclins/biosynthesis , Esophageal Neoplasms/metabolism , Ki-67 Antigen/biosynthesis , Proliferating Cell Nuclear Antigen/biosynthesis , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Retinoblastoma Protein/biosynthesis , Tumor Suppressor Protein p53/biosynthesis , Aged , Carcinoma, Small Cell/pathology , Carcinoma, Squamous Cell/pathology , Cell Division , Cyclin-Dependent Kinase Inhibitor p21 , Esophageal Neoplasms/pathology , Female , Humans , Immunoenzyme Techniques , Male , Middle Aged
12.
Histochem Cell Biol ; 110(6): 589-93, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9860257

ABSTRACT

We immunostained mouse lung tumors using a mouse monoclonal antibody against recombinant Ki-67 antigen (clone; MIB 5) to establish an MIB 5 immunostaining method and to determine the extent of MIB 5 labeling to monitor cell proliferation activity in mouse lung tumors. A/J mice, treated with 4-nitroquinoline 1-oxide, were killed after 18 months. One hour before killing, bromodeoxyuridine (BrdU) was injected intraperitoneally. Lung tissues including tumors were fixed with phosphate-buffered 4% paraformaldehyde and embedded in paraffin. For MIB 5 immunostaining, two antigen-retrieval buffers, citrate buffer pH 6 and TRIS-HCl buffer pH 9.5 containing 5% urea, were tested, and constant and reproducible staining was obtained only with the TRIS-HCI buffer. The mean values of the MIB 5-positive cell index (PCI), the BrdU labeling index (LI), and the mitotic cell count for adenocarcinomas were 4.6%, 2.3%, and 7/mm2, and those for adenomas were 1.2%, 0.7%, and 1.3/mm2, respectively. Each of these values was significantly higher for adenocarcinomas than for adenomas. A close correlation was seen between the MIB 5 PCI and the BrdU LI for adenocarcinomas and adenomas and between the MIB 5 PCI and the mitotic cell count in adenocarcinomas. Thus, MIB 5 immunostaining is a useful method for assessing the proliferative activity of mouse tumor tissues.


Subject(s)
Adenocarcinoma/metabolism , Adenoma/metabolism , Ki-67 Antigen/metabolism , Lung Neoplasms/metabolism , 4-Nitroquinoline-1-oxide/toxicity , Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Adenoma/chemically induced , Adenoma/pathology , Animals , Antibodies, Monoclonal , Bromodeoxyuridine/metabolism , Carcinogens/toxicity , Cell Count , Cell Division/drug effects , Immunoenzyme Techniques , Lung Neoplasms/chemically induced , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred A , Recombinant Proteins/metabolism
13.
Cancer Lett ; 125(1-2): 83-8, 1998 Mar 13.
Article in English | MEDLINE | ID: mdl-9566700

ABSTRACT

The pulmonary tumorigenicity of dimethylarsinic acid (DMAA), a main metabolite of inorganic arsenics, was examined in A/J mice fed with drinking water containing DMAA for 25 and 50 weeks. Mice fed with 400 ppm DMAA for 50 weeks produced more pulmonary tumors than untreated mice (mean number per animal 1.36 versus 0.50; P < 0.05). Histological examination revealed that the number of mice which bore adenocarcinomas or papillary adenomas correlated with the concentration of DMAA given (untreated versus 400 ppm; P = 0.002), suggesting that DMAA could promote tumorigenic processes. These results are consistent with the epidemiological studies on the pulmonary carcinogenesis of arsenics and suggest that DMAA alone can act as a carcinogen in mice.


Subject(s)
Cacodylic Acid/toxicity , Carcinogens/toxicity , Lung Neoplasms/chemically induced , Animals , Genes, ras , Lung Neoplasms/pathology , Male , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...